Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7640853 | 1.00 | CES2 (0.59) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL7634052 | 1.00 | CES2 (0.59) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL5393755 | 0.98 | CES2 (0.55) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL874374 | 0.93 | CES2 (0.48) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL7644723 | 0.87 | — | — | |
| SCHEMBL10009844 | 0.81 | CES2 (0.46) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL10009607 | 0.81 | CES2 (0.46) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL10009837 | 0.81 | CES2 (0.46) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL10009603 | 0.81 | CES2 (0.46) | CES2CES1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL18473773 | 0.80 | CES2 (0.46) | CES2CES1HDAC8HDAC6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120004771-A | Method for producing organic sulfinate compound | 中国石油化工股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| US-9487602-B2 | Furan based resin, process for the preparation thereof, and use of the compound | DSM IP ASSETS B.V. (NL) | 2016-11-08 | — | — | US | claimed |
| US-20130109822-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP ASSETS B.V. (NL) | 2013-05-02 | — | — | US | claimed |
| US-20110306735-A1 | PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF | DSM IP ASSETS B.V. (NL) | 2011-12-15 | — | — | US | claimed |
| US-20110021740-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP ASSETS B.V. (NL) | 2011-01-27 | — | — | US | claimed |
| EP-2222656-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP Assets B.V. (NL) | 2010-09-01 | — | — | EP | claimed |
| US-20090203851-A1 | Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof | DSM IP ASSETS B.V. (NL) | 2009-08-13 | — | — | US | claimed |
| WO-2009077587-A1 | FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND | DSM IP ASSETS B.V. (NL) | 2009-06-25 | — | — | WO | claimed |
| EP-2024317-A2 | PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF | DSMIP Assets B.V. (NL) | 2009-02-18 | — | — | EP | claimed |
| WO-2007140941-A2 | PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF | DSM IP ASSETS B.V. (NL) | 2007-12-13 | — | — | WO | claimed |
| CN-1434815-A | Method for the production of 2-coumarone and substituted 2-coumarones | DSM FINE CHEM AUSTRIA GMBH (AT) | 2003-08-06 | — | — | CN | claimed |
| CN-120004771-A | Method for producing organic sulfinate compound | 中国石油化工股份有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-115175658-A | Perfume system for perfumed consumer products | 弗门尼舍有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-108738320-A | 4- amino -2- (1H- pyrazolos [3 as the cGMP conditioning agents for treating angiocardiopathy, 4-b] pyridin-3-yl) -6- oxos -6,7- dihydro -5H- pyrrolo-es [2,3-d] pyrimidine derivatives and respective (1H- indazole -3- bases) derivative | 默沙东公司 | 2018-11-02 | — | — | CN | disclosed |
| US-9487602-B2 | Furan based resin, process for the preparation thereof, and use of the compound | DSM IP ASSETS B.V. (NL) | 2016-11-08 | — | — | US | disclosed |
| CN-1434815-A | Method for the production of 2-coumarone and substituted 2-coumarones | DSM FINE CHEM AUSTRIA GMBH (AT) | 2003-08-06 | — | — | CN | disclosed |
| US-6348617-B1 | REACTING PYRUVIC ACID COMPOUND IN WATER WITH AMMONIUM OR ALKALI METAL BISULFITE TO GIVE AQUEOUS SOLUTION OF BISULFITE ADDUCT, ISOLATING BY PHASE SEPARATION, OPTIONALLY USING HYDROPHOBIC SOLVENT, CONTACTING WITH ACID TO DECOMPOSE ADDUCT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-19 | — | — | US | disclosed |
| WO-2000053313-A2 | LANTHANIDE CATALYSTS FOR SYNTHESIS OF COMPOUNDS AND COMBINATORIAL LIBRARIES | ARQULE, INC. (US) | 2000-09-14 | — | — | WO | disclosed |
| EP-0937703-A1 | METHOD FOR PURIFYING PYRUVIC ACID COMPOUNDS | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1999-08-25 | — | — | EP | disclosed |
| EP-0003301-A1 | N-Sulfenyl-carbamoyl-oximes, preparation thereof and use thereof as insecticides, acaricides, nematocides | BAYER AG (DE) | 1979-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203851-A1 | Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof | HRH3, HRH1, C9 | CES2 973/4885CES1 2109/4885HDAC8 3184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.